Laxmi Dental Board Approves Amalgamation with Subsidiary Bizdent Devices
Laxmi Dental Limited's board meeting on March 26, 2026, resulted in approval of a comprehensive amalgamation scheme with wholly-owned subsidiary Bizdent Devices Private Limited under Companies Act provisions. The merger aims to consolidate operations, enhance financial strength, and create operational synergies. Key appointments include tax and internal auditors, while three executives received strategic designation changes to strengthen operational leadership across business divisions.

*this image is generated using AI for illustrative purposes only.
Laxmi Dental Limited's Board of Directors held a significant meeting on March 26, 2026, approving multiple strategic decisions including a major amalgamation scheme and key corporate appointments. The meeting, which commenced at 05:00 P.M. (IST) and concluded at 06:05 P.M. (IST), addressed several critical business matters under Regulation 30 of SEBI Listing Regulations.
Scheme of Amalgamation Approved
The board approved a comprehensive scheme of amalgamation between Bizdent Devices Private Limited (Transferor Company) and Laxmi Dental Limited (Transferee Company) under Sections 230 and 233 of the Companies Act, 2013. The scheme is subject to necessary statutory and regulatory approvals, including approval from the Regional Director, Stock Exchanges, and other regulatory authorities.
| Parameter: | Details |
|---|---|
| Transferor Company: | Bizdent Devices Private Limited (CIN: U33203MH2021PTC357799) |
| Transferee Company: | Laxmi Dental Limited (CIN: L51507MH2004PLC147394) |
| Business Focus - Transferor: | Manufacture, distribution and sale of aligner devices, retainer devices, sleep apnoea devices, and sports guards |
| Business Focus - Transferee: | Artificial dentures, dental prosthesis, dental implants, and export-oriented dental products |
| Relationship: | Wholly-owned subsidiary merger |
The amalgamation is designed to consolidate businesses and create operational synergies while establishing a stronger financial base. Key benefits include improved organizational capability, enhanced cash management efficiency, cost savings through rationalization of business processes, and elimination of administrative duplication.
Financial Position of Merging Entities
The financial details of both companies demonstrate substantial business operations across multiple periods:
| Particulars: | Transferor Company (Dec 2025) | Transferee Company (Dec 2025) |
|---|---|---|
| Paid-up Share Capital: | 31.27 Million | 109.92 Million |
| Net Worth (Standalone): | 536.18 Million | 2397.06 Million |
| Net Worth (Consolidated): | NA | 2327.09 Million |
| Total Income (Standalone): | 310.77 Million | 1588.55 Million |
| Total Income (Consolidated): | NA | 2100.89 Million |
Key Appointments and Re-appointments
The board approved several important appointments to strengthen the company's operational framework:
Tax Auditor Re-appointment:
| Parameter: | Details |
|---|---|
| Firm: | M/s. Abhay Subhash & Associates, Chartered Accountants |
| Term: | Financial year 2025-26 |
| Date: | March 26, 2026 |
| Profile: | Leading Mumbai-based CA firm founded in 1984, offering comprehensive audit, taxation, and financial consultancy services |
Internal Auditor Appointment:
| Parameter: | Details |
|---|---|
| Firm: | M/s. Bathiya Advisors LLP, Chartered Accountants |
| Term: | Financial year 2026-27 |
| Date: | March 26, 2026 |
| Profile: | Full-service firm with 16 offices across India and Middle East, member of TAG Alliances |
Executive Designation Changes
The board approved strategic designation changes for key executives to enhance operational leadership:
| Executive: | Previous Designation | New Designation | Effective Date |
|---|---|---|---|
| Mr. Mitesh Kariya: | Director & Associates | Chief Operating Officer – Illusion Dental | March 26, 2026 |
| Mr. Arun Babu John: | Vice President – Sales and Business Development | Chief Revenue Officer – Illusion Dental | March 26, 2026 |
| Mr. Manan Khakhar: | Business Head | CEO – Vedia Solutions | March 26, 2026 |
Policy Updates and ESOP Surrender
The board approved amendments to 17 corporate policies in compliance with latest SEBI regulations, including Nomination and Remuneration Policy, Risk Management Policy, Corporate Social Responsibility Policy, and various codes of conduct.
Additionally, the board noted the surrender of 32,538 Employee Stock Options by Mr. Mitesh Kariya under the Laxmi Dental Employee Stock Option Scheme 2024:
| Parameter: | Details |
|---|---|
| Employee: | Mr. Mitesh Kariya |
| Options Surrendered: | 32,538 |
| Date: | March 26, 2026 |
| Outstanding Options: | 49,000 |
| Status: | Cancelled and returned to pool for future grants |
Related Party Transaction Compliance
The amalgamation involves related parties as Bizdent Devices is a wholly-owned subsidiary of Laxmi Dental Limited. However, the Ministry of Corporate Affairs has clarified that transactions under Compromise, Arrangements and Amalgamations provisions do not fall within related party transaction purview under Section 188 of the Companies Act, 2013. Furthermore, SEBI Listing Regulation 23(5)(b) exempts related party transaction provisions between holding companies and wholly-owned subsidiaries.
Historical Stock Returns for Laxmi Dental
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.65% | -9.44% | -18.31% | -50.36% | -64.99% | -71.42% |
How will the amalgamation impact Laxmi Dental's market positioning in the digital dentistry and orthodontic device segments?
What timeline is expected for obtaining the necessary regulatory approvals from SEBI, stock exchanges, and the Regional Director?
Will the consolidated entity pursue additional acquisitions in the dental technology space to further expand its product portfolio?


































